Stonepine Capital Management »

Surrozen shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 110k 11.98
2024-06-30 $724k 66k 10.95

More positions owned by Stonepine Capital Management

Adma Biologics (ADMA)
Evolus (EOLS)
Galapagos Nv Spon Adr (GLPG)
Jazz Pharmaceuticals Plc Us Listed Shs Usd (JAZZ)
Royalty Pharma Shs Class A (RPRX)
Xoma Corp Com New (XOMA)
Rigel Pharmaceuticals (RIGL)
Zevra Therapeutics Com New (ZVRA)
Anika Therapeutics (ANIK)
Revance Therapeutics (RVNC)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Verastem Com New (VSTM)
Optinose (OPTN)
Urogen Pharma (URGN)
Scpharmaceuticals (SCPH)

View all positions for Stonepine Capital Management

Top funds holding Surrozen

RA Capital Management
Armistice Capital
Nantahala Capital Management
Stempoint Capital
Stonepine Capital Management
Euclidean Capital
CVI Holdings
Vanguard Group
Arrowpoint Asset Management
Board of Trustees of The Leland Stanford Junior University
Morgan Stanley
Heights Capital Management
T. Rowe Price Associates
Alyeska Investment Group
Geode Capital Management

View all funds holding Surrozen